Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Compared to Estimates, Expeditors International (EXPD) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Expeditors International (EXPD) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Expeditors International (EXPD) reported revenue of $2.89 billion, down 3.5% over the same period last year. EPS came in at $1.64, compared to $1.63 in the

Compared to Estimates, Palantir Technologies (PLTR) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Palantir Technologies (PLTR) Q3 Earnings: A Look at Key Metrics

Palantir Technologies Inc. (PLTR) reported $1.18 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 62.8%. EPS of $0.21 for the same period compares

Can Fidelity National Beat Q3 Earnings on Banking Solutions Strength?Photo, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/6a5872d8-cc25-46f8-b436-bf3db1953908.png
Can Fidelity National Beat Q3 Earnings on Banking Solutions Strength?

Financial services technology solutions provider Fidelity National Information Services, Inc. FIS is set to report third-quarter 2025 results on Nov. 5, 2025, before the opening bell. The Zacks

AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales
AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales

Axsome Therapeutics AXSM incurred a loss of 94 cents per share in the third quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 82 cents. The company had incurred a loss of $1.34

TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised
TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised

TG Therapeutics TGTX reported earnings of $2.43 per share for the third quarter of 2025, which significantly beat the Zacks Consensus Estimate of 24 cents. The company had reported earnings of 2

Can These 5 Electronics Stocks Hit Earnings Targets This Season?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
Can These 5 Electronics Stocks Hit Earnings Targets This Season?

The electronics stocks market's quarterly releases are expected to reflect the continued expansion of artificial intelligence infrastructure and data centre buildouts globally. Accelerated

Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates

Tango Therapeutics, Inc. (TNGX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.27 per share a year ago

CDW's Q3 Earnings & Revenues Top Estimates, Up Y/Y on Cloud TailwindsPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
CDW's Q3 Earnings & Revenues Top Estimates, Up Y/Y on Cloud Tailwinds

CDW Corporation (CDW) reported third-quarter 2025 non-GAAP earnings per share (EPS) of $2.71, surpassing the Zacks Consensus Estimate of $2.53. Also, the bottom line increased 3% year over year.

The

Premier, Inc. (PINC) Tops Q1 Earnings and Revenue Estimates
Premier, Inc. (PINC) Tops Q1 Earnings and Revenue Estimates

Premier, Inc. (PINC) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.34 per share a year ago. These

Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

The market expects Viridian Therapeutics, Inc. (VRDN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This

Will Plug Power (PLUG) Report Negative Q3 Earnings? What You Should Know
Will Plug Power (PLUG) Report Negative Q3 Earnings? What You Should Know

The market expects Plug Power (PLUG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

SKYX Platforms Corp. (SKYX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
SKYX Platforms Corp. (SKYX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when SKYX Platforms Corp. (SKYX) reports results for the quarter ended September 2025. While this widely-known

Sky Harbour Group Corporation (SKYH) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Sky Harbour Group Corporation (SKYH) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

The market expects Sky Harbour Group Corporation (SKYH) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Orchestra BioMed Holdings, Inc. (OBIO) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Ondas Holdings Inc. (ONDS) Expected to Beat Earnings Estimates: Should You Buy?
Ondas Holdings Inc. (ONDS) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Ondas Holdings Inc. (ONDS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Ovid Therapeutics (OVID) reports results for the quarter ended September 2025. While this widely-known consensus

Compared to Estimates, NNN REIT (NNN) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, NNN REIT (NNN) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, NNN REIT (NNN) reported revenue of $229.77 million, up 5.3% over the same period last year. EPS came in at $0.86, compared to $0.53 in the year-ago quarter.

The

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics, Inc. (BOLT) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Fate Therapeutics (FATE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

HIVE Digital Technologies (HIVE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
HIVE Digital Technologies (HIVE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year increase in earnings on higher revenues when HIVE Digital Technologies (HIVE) reports results for the quarter ended September 2025. While this widely-known

Hamilton Lane (HLNE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Hamilton Lane (HLNE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Hamilton Lane (HLNE) reported revenue of $190.88 million, up 27.3% over the same period last year. EPS came in at $1.54, compared to $1.07 in the year-ago

Marriott (MAR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Marriott (MAR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Marriott International (MAR) reported revenue of $6.49 billion, up 3.7% over the same period last year. EPS came in at $2.47, compared to $2.26 in the year-ago

Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

The market expects Opus Genetics, Inc. (IRD) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Compared to Estimates, Hertz Global (HTZ) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Hertz Global (HTZ) Q3 Earnings: A Look at Key Metrics

Hertz Global Holdings, Inc. (HTZ) reported $2.48 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3.8%. EPS of $0.12 for the same period compares to

Evolution Petroleum (EPM) Reports Next Week: What You Should Expect
Evolution Petroleum (EPM) Reports Next Week: What You Should Expect

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Evolution Petroleum (EPM) reports results for the quarter ended September 2025. While this widely-known